首页 | 本学科首页   官方微博 | 高级检索  
检索        


Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death
Authors:Carlo Visco  Maria C Tisi  Andrea Evangelista  Alice Di Rocco  Anna-Katharina Zoellner  Vittorio R Zilioli  Stefan Hohaus  Roberta Sciarra  Alessandro Re  Cristina Tecchio  Annalisa Chiappella  Lucia Morello  Guido Gini  Luca Nassi  Tommasina Perrone  Anna L Molinari  Alberto Fabbri  Maria C Cox  Erica Finolezzi  Simone Ferrero  Benedetta Puccini  Isabel Alvarez De Celis  Annalisa Arcari  Dario Marino  Michele Merli  Francesco Piazza  Massimo Gentile  Matteo Pelosini  Giacomo Loseto  Olivier Hermine  Martin Dreyling  Marco Ruggeri  Maurizio Martelli  Eva Hoster  Umberto Vitolo  for the Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network
Institution:1. Haematology, San Bortolo Hospital, Vicenza, Italy;2. Clinical Epidemiology, Città della Salute e della Scienza and CPO Piemonte, Torino, Italy;3. Cellular Biotechnologies and Haematology, ‘Sapienza’ University, Rome, Italy;4. Medical Department III, University Hospital Munich, Munich, Germany;5. Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;6. Policlinico Gemelli Foundation, Institute of Haematology, Catholic University of the Sacred Heart, Rome, Italy;7. Haematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;8. Haematology, Spedali Civili, Brescia, Italy;9. Medicine, Section 10. of Haematology and Bone Marrow Transplant Unit, University of Verona, Verona, Italy;11. Haematology, Citta’ della salute e della scienza university hospital, Torino, Italy;12. Haematology, Humanitas Clinical and Research Center, Rozzano, Italy;13. Haematology Clinic, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ospedali Riuniti di Ancona, Ancona, Italy;14. Haematology Department, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy;15. Department of Emergency and Organ Transplantation, Haematology Section, University of Bari, Bari, Italy;16. Haematology, Ospedale degli Infermi, Rimini, Italy;17. Unit of Haematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy;18. Haematology unit, AOU Sant'Andrea, Rome, Italy;19. Haematology, Transfusional Medicine and Biotechnologies, UOSD “Centro Diagnosi e Terapia dei Linfomi”, PO Santo Spirito, Pescara, Italy;20. Molecular Biotechnologies and Health Sciences, University of Torino/AOU “Città della Salute e della Scienza di Torino”, Torino, Italy;21. Haematology, University of Firenze, Firenze, Italy;22. Haematology Unit, AUSLL/IRCCS Santa Maria Nuova Hospital, Reggio Emilia, Italy;23. Haematology and Bone Marrow Transplant Unit, “Guglielmo da Saliceto” Hospital, Piacenza, Italy;24. Medical Oncology 1, Veneto Institute of Oncology IOV IRCCS, Padova, Italy;25. Haematology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy;26. Haematology, Department of Medicine, University of Padova, Padova, Italy;27. Onco-haematology, Haematology Unit, AO of Cosenza, Cosenza, Italy;28. Clinical and Experimental Medicine, Section 29. of Haematology, University of Pisa, Pisa, Italy;30. IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy;31. Clinical Haematology, Université Sorbonne Paris Cité, Hôpital Necker, Paris, France
Abstract:
Keywords:mantle cell lymphoma  cytarabine  refractory  prognosis  allogeneic transplant
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号